Hims & Hers delivered yet another strong quarter of revenue growth in Q3, with sales climbing 49% year over year to $599 ...

Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q3 CY2025 results , with sales up 49.2% year on year to $599 ...

Earnings Rewind: AMD, Uber, & Hims Bet on the Future as Robinhood & DraftKings Shock Wall Street Time In the Market Record ...

Shares of Hims & Hers Inc. fell after hours on Monday after the wellness and telehealth platform's third-quarter forecast came up shy of Wall Street's estimates, although the company stuck with its ...

This article was reviewed by Knox Beasley, MD. Rogaine vs Minoxidil: What’s Best for Hair Growth? Growing up, you may have ...

I remain bullish on Hims & Hers Health due to its resilient subscriber growth and strong positioning in the expanding personalized care and telehealth markets. Despite the loss of the GLP-1 contract ...

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble ...

Hims is now a GARP stock, combining rapid revenue and subscriber growth with a lower, fair valuation after a recent selloff. The company’s scalable model, product launches, and global expansion plans ...

The telehealth platform said revenue rose 49% to $599 million in the latest quarter.

Hims does not yet have an agreement with Novo and there’s “a possibility that no definitive agreement may ever be executed ...

Hair growth and loss prevention is a big industry. Market intelligence agency Business Research Insights projected it to hit ...